View full meeting coverage »

Eyetube Meeting Coverage:

Retina Updates Spring 2020

 

Editorially Independent Content, Financially Supported by

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

HtrA1 Inhibition for Dry AMD

  Channels: Retina | Posted 5/13/2020

Dante Pieramici, MD, explains potential benefits to targeting HtrA1 protein in patients with dry AMD. Dr. Pieramici outlines the structure and results of a phase 1 trial that sought to evaluate the safety of an anti-HtrA1 agent in patients with geographic atrophy secondary to dry AMD.

Clinical Trials • dry age-related macular degeneration, dry AMD • retina-meeting-recap


3 / 10 Series: Retina Updates Spring 2020


These programs are not affiliated with the official program of ARVO 2020.